Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: Possible involvement of serotonin(2C) receptors

Psychopharmacology

Volumn 150, Issue 1, 2000, Pages 45-51

  Di Matteo, Vincenzo ^a   Di Mascio, Michele ^a   Di Giovanni, Giuseppe ^b   Esposito, Ennio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Amitriptyline; Dopamine release; Mianserin; Microdialysis; Nucleus accumbens

Indexed keywords

2 CHLORO 5 FLUOROINDOL 1 YL 1 METHYLETHYLAMINE FUMARATE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; AMITRIPTYLINE; DOPAMINE; MIANSERIN; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; AMITRIPTYLINE; ANIMALS; DOPAMINE; ETHYLAMINES; INDOLES; MALE; MIANSERIN; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0034094987     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000420     Document Type: Article

References (58)

1. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-668
2. 1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol Pharmacol 44:725-730
3. 2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687-11690
4. 1C receptors in drug induced penile erections in rats. Psychopharmacology 101:57-61
5. Brown AS, Gershon S (1993) Dopamine and depression. J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect 91: 75-109
6. Cervo L, Samanin R (1987) Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology 26:1469-1472
7. Cervo L, Samanin R (1988) Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. J Pharm Pharmacol 40:155-156
8. Cervo L, Grignaschi G, Samanin R (1990) The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test. Eur J Pharmacol 178:129-133
9. De Montis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180: 31-35
10. Frazer A (1997) Antidepressants. J Clin Psychiatry 58 [suppl 6]: 9-25
11. 2C/2B receptors enhances mesostriatal and mesolimbic dopaminergic function. Trends Neurosci 20[suppl]:59
12. 2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587-597
13. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1998a) Role of the serotonergic system in the control of mesocorticolimbic dopaminergic function. Curr Top Pharmacol 4:107-116
14. 2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology 37:265-272
15. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38:1195-1205
16. Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP (1998) Increased levels of extracellular dopamine in neostriatum and nucleus accumbnes after histamine H1 receptor blockade. Naunyn Schmiedeberg's Arch Pharmacol 358: 423-429
17. Fibiger HC (1995) Neurobiology of depression: focus on dopamine. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and mania: from neurobiology to treatment. Raven Press, New York, pp 1-17
18. Giles AR (1987) Guidelines for the use of animals in biomedical research. Thromb Haemost 58:1078-1084
19. Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124:74-86
20. Hertel P, Nomikos GG, Svensson TH (1999) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol 371: 153-158
21. Hervé D, Pickel VM, Jog TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435: 71-83
22. 1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223-229
23. 1C receptors and antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 18:563-574
24. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75-113
25. Kelland MD, Freeman AS, Rubin J, Chiodo LA (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-546
26. 2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427-434
27. 2C receptor antagonist. Neuropharmacology 36:609-620
28. 2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways: a combined dialysis and electrophysiological analysis. Soc Neurosci Abstr 23:975
29. Marcus MM, Nomikos GG, Svensson TH (1996) Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens. Eur Neuropsychopharmacol 6:29-38
30. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913-924
31. Mathe JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996) Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309:1-11
32. Meltzer HY, Chai BL, Thompson PA, Yamamoto BK (1994) Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. J Pharmacol Exp Ther 268:1452-1461
33. 2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur J Pharmacol 325:9-12
34. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953-955
35. 1C receptor activation in rats. Psychopharmacology 110:140-144
36. Moreau J-L, Bourson A, Jenck F, Martin JR, Mortas P (1994) Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression. J Psychiatr Neurosci 19:51-56
37. 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6:169-175
38. Moukhles H, Bosler O, Bolam JP, Vallée A, Umbriaco D, Geffard M, Doucet G (1997) Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76:1159-1171
39. 2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y J Neurochem 69:1031-1038
40. Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147-156
41. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York
42. Plaznik A, Kostowski W (1987) The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur J Pharmacol 135:389-396
43. 1C/2 receptor agonists and antagonists. Eur J Pharmacol 244:1-5
44. Prisco S, Pagannone S, Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271:83-90
45. Richelson E (1996) Synaptic effects of antidepressants. J Clin Psychopharmacol 16[suppl 2]:1S-7S
46. 2C receptor levels. Eur J Pharmacol 262:125-131
47. Saito H, Matsumoto M, Togashi H, Yoshioka M (1996) Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies. Jpn J Pharmacol 70:203-225
48. Sampson D, Winner P, Muscat R (1991) Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 104:491-495
49. Sanders-Bush E, Breeding M (1988) Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus. J Pharmacol Exp Ther 247:169-173
50. 2A receptor blockade. J Pharmacol Exp Ther 277:1541-1549
51. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266: 684-691
52. Steinbusch HWM (1984) Serotonin-immunoreactive neurons and their projections in the CNS. Classical transmitters and transmitter receptors in the CNS. In: Björklund A, Hökfelt T, Kuhar MJ (eds) Handbook of chemical neuroanatomy, vol 3, part II. Elsevier, Amsterdam, pp 68-125
53. Tanda G, Bassareo V, Di Chiara G (1996) Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology 123:127-130
54. Van Bockstaele EJ, Biswas A, Pickel VM (1993) Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens. Brain Res 624:188-198
55. Van Bockstaele EJ, Cestari DM, Pickel VM (1994) Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res 647:307-322
56. Van der Kooy D, Hattori T (1980) Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 186:1-7
57. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436
58. Winner P (1995) Animal models of depression: validity and applications. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and mania: from neurobiology to treatment. Raven Press, New York, pp 19-41